Gujarat Themis Biosyn Ltd - 506879 - Cancellation of Board Meeting
Gujarat Themis Biosyn has cancelled its Board meeting, which was scheduled for June 19, 2026. The company cited unavoidable circumstances as the reason and will announce a revised date soon.
Jun 17 2026 21:18:23
Gujarat Themis Biosyn Ltd - 506879 - Announcement Under Regulation 30 - Updates
Gujarat Themis Biosyn Limited incorporated a new step-down subsidiary, Themis Biosyn Private Limited, in Ireland on June 16, 2026. This move expands the company's international presence in the pharmaceutical industry.
Jun 17 2026 20:34:34
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Inter Alia, To Evaluate Proposal For Raising Funds Through Issue Of Equity Shares / Securities Including Compulsory Convertible Debentures, Optionally Convertible Debentures And Non-Convertible Debentures..
Gujarat Themis Biosyn's Board of Directors will convene on June 19, 2026, to consider a proposal for raising funds. The fundraise may involve issuing equity shares or various convertible debentures through a preferential issue or other methods.
Jun 16 2026 21:21:12
Gujarat Themis Biosyn Ltd - 506879 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Gujarat Themis Biosyn has announced a postal ballot for its members to approve a Qualified Institutional Placement (QIP) for raising funds. The e-voting period for this resolution will run from June 9, 2026, to July 8, 2026, with results expected by July 10, 2026.
Jun 09 2026 14:29:47
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Gujarat Themis Biosyn Limited's Board has proposed a Special Resolution via postal ballot for a Qualified Institutions Placement (QIP) to raise up to ₹1,000 crores. This capital infusion is intended to support the company's growth strategy and fund strategic projects.
Jun 08 2026 23:45:10
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 6Th June, 2026
Gujarat Themis Biosyn's board approved raising funds up to ₹1,000 crores via Qualified Institutions Placement (QIP) and a preferential issue to non-promoters. These proposals are subject to regulatory and shareholder approvals, aiming to bolster the company's financial position.
Jun 06 2026 19:17:20
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Gujarat Themis Biosyn shareholders approved special resolutions to increase borrowing limits and expand inter-corporate investment capabilities. Both resolutions passed with over 98% votes in favour, enabling greater financial flexibility.
Jun 05 2026 12:10:02
Gujarat Themis Biosyn Ltd - 506879 - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Gujarat Themis Biosyn shareholders approved special resolutions to increase borrowing and investment limits. This enhances the company's financial flexibility for future growth and operations.
Jun 05 2026 12:05:39
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Intimation for Consideration And Evaluate The Proposals For Raising Funds By Way Of Issue Of Equity Shares / Securities Through Qualified Institutions Placement Or Preferential Allotment Or Any Other Methods / Modes Or Combination Thereof.
Gujarat Themis Biosyn board will convene on June 6, 2026, to consider and evaluate proposals for raising funds. The fundraise may be through Qualified Institutions Placement (QIP) or preferential allotment.
Jun 03 2026 18:13:19
Gujarat Themis Biosyn Ltd - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Gujarat Themis Biosyn approved FY26 audited financial results, reporting a total income of ₹168.25 crore and a net profit of ₹46.68 crore. The company recommended a final dividend of ₹0.67 per equity share and approved a preferential issue of equity shares.
May 25 2026 15:07:09
Read More